Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN110746393A reveals a metal-free synthesis of 3-methylthio benzofurans using DMSO and SOCl2, offering significant cost reduction and supply chain reliability for API manufacturing.
Novel Lewis acid catalyzed synthesis offers high purity trans-isomer selectivity for pharmaceutical intermediate manufacturing supply chains and significant cost efficiency.
Novel alkaline crystallization method reduces Impurity A below 0.10% ensuring ICH Q3a compliance and supply chain stability for cardiac imaging agents globally.
Advanced synthesis of Regorafenib intermediate using inorganic bases. Safe, scalable, high-yield process for pharmaceutical supply chains.
Patent CN112175034B reveals a novel one-pot synthesis for 17 alpha-hydroxyprogesterone with >94% yield. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN113816913B reveals improved oxazepam intermediate synthesis with reduced waste and enhanced safety for reliable pharmaceutical intermediates supply chains.
Novel convergent synthesis of racemization hanfangchin A offers cost reduction and scalable production for pharmaceutical intermediates supply chain.
Novel one-step catalytic method for pyrido-pyrimidinones. Reduces synthetic steps, improves yield, and ensures supply chain stability for high-purity pharmaceutical intermediates.
Patent CN107954936A reveals a high-yield synthesis route for deuterated imidazole diketone compounds, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN104031029A reveals a one-step synthesis for bepotastine intermediates offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN104884450B details a novel copper-catalyzed route for Voriconazole intermediates offering significant supply chain and cost advantages for global pharmaceutical manufacturers.
Novel ionic liquid method enhances cinacalcet hydrochloride purity and yield offering significant supply chain stability and cost reduction advantages for pharmaceutical manufacturing.
Patent CN115246761B reveals metal-free synthesis for polysubstituted naphthalene derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN115246815A details a novel nicotine preparation method recycling chiral resolution waste, offering high purity and reduced environmental impact for pharmaceutical manufacturers.
Novel patent CN117447387A enables cost-effective chiral intermediate production. Enhances supply chain reliability and purity for global API manufacturing partners.
Patent CN116082181B reveals a cost-effective synthesis route for Alzheimer's intermediates. Achieve high purity without column purification for scalable supply.
Patent CN111004212A reveals high-yield nicotine synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Novel asymmetric synthesis of Beclabuvir intermediate via chiral copper catalysis. High yield, >99% ee, scalable process for API manufacturing.
Novel Raney Nickel catalytic method improves yield and reduces cost for capsaicinoid intermediates. Reliable supply chain partner for pharmaceutical manufacturing.
Patent CN107602412A details a novel purification method for aldehyde oil methanol solution enhancing purity and solvent recovery for sustainable sulphadiazine intermediate manufacturing supply chains.